I am not it, too. I also like to evacuate the effectiveness of PEA in my pain patients. In one of the recent met analysis for PEA in pain conditions; as conclusion; it was suggested that further, well-designed, randomized, placebo-controlled trials was further study should be performed.
So, It is a good opportunity for pain clinicians and pain patients
@DomenicoChirchiglia The idea is good. Now, please carefully look at the literature, and search for simikar data already published. Then, you should convince the companies producing the drug to sponsor such interesting study. I would be ready to help, coordinating the study and following all the publication process.